Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 02-Aug-24 4:05 PM View:  | Cara Therapeutics, Inc. (CARA) | 01-Aug-24 | Sale (Planned) | 4,149 | $0.35 | $1,452.15 | (2%) 176.59K to 172.44K | |
| 06-May-24 4:15 PM View: | Cara Therapeutics, Inc. (CARA) | 02-May-24 | Sale (Planned) | 3,936 | $0.75 | $2,952.00 | (2%) 180.52K to 176.59K | |
| 04-Mar-24 4:19 PM View: | Cara Therapeutics, Inc. (CARA) | 29-Feb-24 | Sale (Planned) | 5,834 | $0.89 | $5,192.26 | (3%) 186.35K to 180.52K | |
| 12-Feb-24 5:10 PM View: | Cara Therapeutics, Inc. (CARA) | 08-Feb-24 | Sale (Planned) | 35,575 | $0.53 | $18,854.70 | (16%) 221.93K to 186.35K | |
| 05-Feb-24 4:26 PM View: | Cara Therapeutics, Inc. (CARA) | 01-Feb-24 | Grant | 62,500 | -- | -- | 38% 164.41K to 226.91K | |
| 05-Feb-24 4:26 PM View: | Cara Therapeutics, Inc. (CARA) | 01-Feb-24 | Sale (Planned) | 4,981 | $0.55 | $2,739.55 | (2%) 226.91K to 221.93K | |
| 03-Nov-23 4:37 PM View: | Cara Therapeutics, Inc. (CARA) | 02-Nov-23 | Sale (Planned) | 3,796 | $1.22 | $4,631.12 | (2%) 168.21K to 164.41K | |
| 04-Aug-23 5:21 PM View: | Cara Therapeutics, Inc. (CARA) | 03-Aug-23 | Sale (Planned) | 4,307 | $3.07 | $13,222.50 | (2%) 172.51K to 168.21K | |
| 09-May-23 4:22 PM View: | Cara Therapeutics, Inc. (CARA) | 05-May-23 | Sale (Planned) | 3,869 | $4.40 | $17,023.60 | (2%) 176.38K to 172.51K | |
| 07-Mar-23 4:47 PM View: | Cara Therapeutics, Inc. (CARA) | 03-Mar-23 | Sale (Planned) | 5,987 | $9.71 | $58,133.80 | (3%) 182.37K to 176.38K | |
| 03-Feb-23 6:38 PM View: | Cara Therapeutics, Inc. (CARA) | 02-Feb-23 | Market Sale (Planned) | 4,191 | $11.80 | $49,453.80 | (2%) 186.56K to 182.37K | (3%) |
| 18-Nov-22 5:23 PM View: | Cara Therapeutics, Inc. (CARA) | 16-Nov-22 | Market Sale (Planned) | 14,470 | $11.13 | $161,051.00 | (7%) 201.03K to 186.56K | (9%) |
| 05-Apr-22 5:48 PM View: | Cara Therapeutics, Inc. (CARA) | 04-Apr-22 | Market Sale (Planned) | 2,006 | $12.67 | $25,416.00 | (< 1%) 203.04K to 201.03K | 4% |
| 01-Mar-22 4:17 PM View: | Cara Therapeutics, Inc. (CARA) | 25-Feb-22 | Grant | 39,000 | -- | -- | 24% 164.04K to 203.04K | |
| 03-Nov-21 8:15 AM View: | Cara Therapeutics, Inc. (CARA) | 29-Oct-21 | Grant | 147,941 | -- | -- | 919% 16.1K to 164.04K | |
| 07-Jun-21 7:33 PM View: | Cara Therapeutics, Inc. (CARA) | 07-Jun-21 | Market Sale (Planned) | 2,304 | $13.04 | $30,044.20 | (13%) 18.4K to 16.1K | |
| 07-Jun-21 7:33 PM View: | Cara Therapeutics, Inc. (CARA) | 03-Jun-21 | Grant | 7,200 | -- | -- | 64% 11.2K to 18.4K | |
| 23-Nov-20 8:28 PM View: | Cara Therapeutics, Inc. (CARA) | 19-Nov-20 | Market Sale | 2,000 | $15.82 | $31,638.00 | (15%) 13.2K to 11.2K | < 1% |
| 08-Jun-20 5:46 PM View: | Cara Therapeutics, Inc. (CARA) | 04-Jun-20 | Grant | 7,200 | -- | -- | 120% 6.0K to 13.2K | |
| 06-Jun-19 6:03 PM View: | Cara Therapeutics, Inc. (CARA) | 04-Jun-19 | Grant | 6,000 | -- | -- | 100% 0 to 6.0K |